REGN Regeneron Pharmaceuticals, Inc.

920.69USD-0.29%Mkt Cap: 95.24B USDP/E: 20.35

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammator…